Rhabdomyolysis is a potentially lethal syndrome that follows skeletal muscle injury, both traumatic and nontraumatic. The literature on this syndrome remains sketchy, and rhabdomyolysis may often go unrecognized. The history, clinical presentation, laboratory findings, etiology, and treatment of rhabdomyolysis are reviewed. Factors which predispose psychiatric patients in particular to this syndrome are discussed. Recommendations to reduce morbidity and mortality are offered.
Get full access to this article
View all access options for this article.
References
1.
KnochelJ. P., Rhabdomyolysis and Myoglobinuria, Annual Review of Medicine, 33, pp. 435–443, 1982.
2.
GabowP. A.KaehnyW. D., and KelleherS. P., The Spectrum of Rhabdomyolysis, Medicine, 61, pp. 141–152, 1982.
3.
MartinD. W.WattsH. D., and SmithL. H., Rhabdomyolysis-Medical Staff Conference, University of California, San Francisco, Western Journal of Medicine, 125, pp. 298–304, 1976.
4.
FinlaysonR. E. and CavanaughJ. J., Drs. Finlayson and Cavanaugh Reply, Journal of Clinical Psychiatry, 46, p. 406, 1985.
5.
CavanaughJ. J. and FinlaysonR. E., Rhabdomyolysis Due to Acute Dystonic Reaction to Antipsychotic Drugs, Journal of Clinical Psychiatry, 45, pp. 356–357, 1984.
6.
RalphD., Rhabdomyolysis and Acute Renal Failure, JACEP, 7, pp. 103–106, 1978.
7.
JohnsonS. B.AlvarezW. A., and FreinharJ. P., A Case of Massive Rhabdomyolysis Following Molindone Administration, Journal of Clinical Psychiatry, 47, pp. 607–608, 1986.
8.
CoryellW.NorbyL. H., and CohenL. H., Psychosis-induced Rhabdomyolysis, Lancet, 2, pp. 381–382, 1978.
9.
EiserA. R.NeffM. S., and SlifkinR. F., Acute Myoglobinuric Renal Failure: A Consequence of the Neuroleptic Malignant Syndrome, A rehires of Internal Medicine, 142, pp. 601–603, 1982.
10.
DenboroughM. A.CollinsS. P., and HopkinsonK. C., Rhabdomyolysis and Malignant Hyperpyrexia, British Medical Journal, 288, p. 1878, 1984.
11.
ThaseM. E. and ShostakM., Rhabdomyolysis Complicating Rapid Intramuscular Neuroleptization, Journal of Clinical Psychopharmacology, 4, pp. 46–48, 1984.
12.
SwensonR. D.GolperT. A., and BennettW. M., Acute Renal Failure and Rhabdomyolysis After Ingestion of Phenylpropanolamine-containing Diet Pills, Journal of the American Medical Association, 248, p. 1216, 1982.
13.
HampelG.HorstkotteH., and RumpfK. W., Myoglobinuric Renal Failure Due to Drug-induced Rhabdomyolysis, Human Toxicology, 2, pp. 197–203, 1983.
14.
CaruanaR. J.DilworthL. R., and WillifordP. M., Acute Rhabdomyolysis Associated with an Overdose of Lorazepam, Perphenazine and Amitriptyline, North Carolina Medical Journal, 44, pp. 18–19, 1983.
15.
TarnC. W.OlinB. R., and RuizA. E., Loxapine-associated Rhabdomyolysis and Acute Renal Failure, Archives of Internal Medicine, 140, pp. 975–976, 1980.
16.
JankovicJ. and PennA. S., Severe Dystonia and Myoglobinuria, Neurology, 32, pp. 1195–1197, 1982.
17.
AbreoK.ShelpW. D.KosseffA., Amoxapine-associated Rhabdomyolysis and Acute Renal Failure: Case Report, Journal of Clinical Psychiatry, 43, pp. 426–427, 1982.
18.
SergentE., Les Cailles Empoisonneuses en France: Duexieme Note, Arch Inst Pasteur Alger, 26, pp. 249–252, 1948.
19.
OuzounellisT., Some Notes on Quail Poisoning, Journal of the American Medical Association, 211, pp. 1186–1187, 1970.
20.
BillisA. G.KastanakisS.GiamarellouH., Acute Renal Failure After a Meal of Quail, Lancet, 2, p. 702, 1971.
21.
Meyer-BetzF., Beobachtungen an Einem Eigenartigen mit Muskellahmungen Verbunden Fall von Hamoglobinurie, Dtsch Arch KlinMed, 101, p. 85, 1911.
22.
BywatersE. G. L. and BeallD., Crush Injuries with Impairment of Renal Function, British Medical Journal, 1, pp. 427–432, 1941.
23.
CadnapaphornchaiP.TaherS., and McDonaldF. D., Acute Drug-associated Rhabdomyolysis: An Examination of Its Diverse Renal Manifestations and Complications, American Journal of Medical Science, 280, pp. 66–72, 1980.
24.
LazarusA., Psychiatric Patients at High Risk for Rhabdomyolysis, Journal of Clinical Psychiatry, 46, p. 406, 1985.
25.
EngelW. K. and MeltzerH. Y., Histochemical Abnormalities of Skeletal Muscle in Patients with Acute Psychoses, Science, 168, pp. 273–276, 1970.
26.
MeltzerH. Y., Creatine Kinase and Aldolase in Serum: Abnormality Common to Acute Psychoses, Science, 159, pp. 1368–1370, 1968.
27.
MeltzerH. Y.Ross-StantonJ., and SchlessingerS., Mean Serum Creatine Kinase Activity in Patients with Functional Psychoses, Archives of General Psychiatry, 37, pp. 650–655, 1980.
28.
HarveyS. C., Hypnotics and Sedatives, in The Pharmacological Basis of Therapeutics, 6th Edition, GilmanA. G.GoodmanL. S., and GilmanA. (eds.), 1980.
29.
MertzB., Malignant Hyperthermia: Nightmare for Anesthesiologists—and Patients, Journal of the American Medical Association, 255, pp. 709–715, 1986.
30.
PaasukeR. T. and BrownellA. K. W., Serum Creatine Kinase Level as a Screening Test for Susceptibility to Malignant Hyperthermia, Journal of the American Medical Association, 255, pp. 679–771, 1986.
31.
MertzB., Defect of Intracellular Calcium Channels is Culprit in Malignant Hyperthermia, Journal of the American Medical Association, 255, pp. 710–711, 1986.
